Approximately 40% of cancer-related clinical trials terminate prematurely, 1 which results in an immense loss of time, money, and human effort. Failure to optimize clinical trial design, inefficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback